Physician profile
Mark Leslie Witkowski
NPI 1982998100
$7,530.07
in general payments reported to CMS, 2019-2025
11 companies · $60.95 in 2025
The $60.95 reported for 2025 was less than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $71.69 · 2020: $109 · 2021: $401 · 2022: $6,726 · 2023: $94.43 · 2024: $67.88 · 2025: $60.95.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $223.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $223.26 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $7,183.20 | 2020-2025 | Da Vinci Surgical System |
| Misonix INC | $68.81 | 2019-2020 | |
| Davol INC. | $52.07 | 2022-2024 | Phasix Mesh |
| Endogastric Solutions, INC | $47.16 | 2021 | |
| Portola Pharmaceuticals, LLC | $41.13 | 2019-2020 | |
| Sanara Medtech INC. | $39.50 | 2025 | Celleraterx |
| Pacira Pharmaceuticals Incorporated | $37.61 | 2024 | Exparel |
| Tela Bio, INC. | $19.34 | 2019 | |
| Eagle Pharmaceuticals, INC. | $17.08 | 2023 | |
| Convatec INC. | $12.66 | 2019 | |
| W. L. Gore & Associates, INC. | $11.51 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Witkowski listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.